Alex Gorsky
Net Worth

Last updated:

What is Alex Gorsky net worth?

The estimated net worth of Mr. Alex Gorsky is at least $130,089,244 as of 17 Jan 2023. He owns shares worth $60,089,244 as insider and has received compensation worth at least $70,000,000 in Johnson & Johnson.

What is the salary of Alex Gorsky?

Mr. Alex Gorsky salary is $5,000,000 per year as Executive Chairman in Johnson & Johnson.

How old is Alex Gorsky?

Mr. Alex Gorsky is 65 years old, born in 1960.

What stocks does Alex Gorsky currently own?

As insider, Mr. Alex Gorsky owns shares in one company:

Company Title Shares Price per share Total value
Johnson & Johnson (JNJ) Executive Chairman 336,559 $178.54 $60,089,244

What does Johnson & Johnson do?

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ logo
JNJ
Johnson & Johnson
$178.54

Alex Gorsky insider trading

Johnson & Johnson

Mr. Alex Gorsky has made only one insider trade between 2011-2023, according to the Form 4 filled with the SEC.

As of 17 Jan 2023 he still owns at least 336,559 units of JNJ stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Options (Right to Buy) 547,692 $72.54 $39,729,578
Option
Common Stock 547,692 $72.54 $39,729,578
Option
Common Stock 60,965 N/A N/A
Option
Performance Share Units 60,965 N/A N/A
Option
Common Stock 11,129 N/A N/A
Option
Restricted Share Units 11,129 N/A N/A
Option
Employee Stock Options (Right to Buy) 231,951 $65.37 $15,162,637
Option
Common Stock 231,951 $65.37 $15,162,637
Option
Common Stock 75,105 N/A N/A
Option
Performance Share Units 63,088 N/A N/A
Option
Common Stock 75,105 N/A N/A
Option
Common Stock 107,016 N/A N/A
Option
Performance Share Units 75,237 N/A N/A
Option
Performance Share Units 73,947 N/A N/A
Option
Common Stock 73,947 N/A N/A
Option
Common Stock 29,579 N/A N/A
Option
Restricted Share Units 29,579 N/A N/A
Option
Employee Stock Options (Right to Buy) 144,695 N/A N/A
Option
Common Stock 264,465 N/A N/A
Sale
Common Stock 264,465 N/A N/A
Option
Performance Share Units 82,913 N/A N/A
Option
Common Stock 82,913 N/A N/A
Option
Restricted Share Units 33,165 N/A N/A
Option
Common Stock 33,165 N/A N/A
Option
Performance Share Units 84,299 N/A N/A
Option
Common Stock 84,299 N/A N/A
Option
Restricted Share Units 33,720 N/A N/A
Option
Common Stock 33,720 N/A N/A
Option
Common Stock 67,933 N/A N/A
Option
Performance Share Units 67,933 N/A N/A
Option
Restricted Share Units 27,173 N/A N/A
Option
Common Stock 27,173 N/A N/A
Option
Common Stock 42,112 N/A N/A
Option
Performance Share Units 42,112 N/A N/A
Option
Common Stock 16,845 N/A N/A
Option
Restricted Share Units 16,845 N/A N/A
Option
Common Stock 12,058 N/A N/A
Option
Restricted Share Units 12,058 N/A N/A
Option
Restricted Share Units 9,981 N/A N/A
Option
Common Stock 9,981 N/A N/A
Option
Common Stock 20,791 N/A N/A
Option
Restricted Share Units 73,800 N/A N/A
Option
Common Stock 73,800 N/A N/A

Johnson & Johnson key executives

Johnson & Johnson executives and other stock owners filed with the SEC: